{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-060319","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.364022+00:00","generated_at":"2026-06-13T00:49:30.273095+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Vicarious Surgical updates corporate presentation, targeting 2025 launch vs $150B market","bullets":["$150B addressable abdominal market; 96% of procedures still manual per company estimates.","Partnerships with three leading health systems (HCA, UPMC, etc.) covering >200 hospitals.","Roadmap: Beta 2 build in 2023, version 1.0 design lock and FDA De Novo submission in 2024.","First clinical patient expected in 2024, commercial launch targeted for 2025.","Decoupled actuator technology enables 1.8cm single-port access with 13 degrees of freedom per arm."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-060319","json":"https://secwatch.observer/filing/0001213900-23-060319.json","markdown":"https://secwatch.observer/filing/0001213900-23-060319.md","text":"https://secwatch.observer/filing/0001213900-23-060319.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390023060319/0001213900-23-060319-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390023060319/ea182474-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T00:49:30.273095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}